Survivors of childhood, adolescent, and young adult cancer, previously treated with
anthracycline chemotherapy (including mitoxantrone) or radiotherapy in which the heart was …

Survivors of childhood cancer treated with anthracycline chemotherapy or chest radiation
are at an increased risk of developing congestive heart failure. In this population, congestive …

We used a multifunctional mesoporous silica nanoparticle (MSNP) carrier to overcome
doxorubicin (Dox) resistance in a multidrug resistant (MDR) human breast cancer xenograft …

This document was approved by the American College of Cardiology Foundation (ACCF)
Board of Trustees in August 2012 and by the following societies in August 2012: American …

Purpose Interindividual variability in the dose-dependent association between
anthracyclines and cardiomyopathy suggests that genetic susceptibility could play a role …

Objectives To review the evidence for the use of various biomarkers in the detection of
chemotherapy associated cardiac damage. Design and methods Pubmed. gov was queried …

Background The level of serum cardiac troponin-T (cTnT) increases with myocardial
damage. We sought to assess whether cTnT level could be a useful marker for the early …

Simple Summary Cardiac biomarkers have proved increasingly useful in the various
branches of cardiology, not sparing the field of cardio-oncology. With specific reference to …

Multi-modality cancer treatments that include chemotherapy, radiation therapy, and targeted
agents are highly effective therapies. Their use, especially in combination, is limited by the …

Although heart failure is predominantly caused by cardiovascular conditions such as
hypertension, coronary heart disease and valvular heart disease, it can also be an adverse …